What is the global market size of Menopause Market?

Menopause Market size was valued at USD 16.01 billion in 2021 and is poised to grow from USD 16.9 billion in 2022 to USD 24.4 billion by 2030, growing at a CAGR of 5.33% in the forecast period (2023-2030).

Who are the key vendors in the Global Menopause Market?

With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Pfizer Inc.', 'Novo Nordisk A/S', 'Allergan plc', 'TherapeuticsMD Inc.', 'Mylan N.V.', 'Teva Pharmaceutical Industries Ltd.', 'Bayer AG', 'Merck & Co. Inc.', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Eli Lilly and Company', 'Amgen Inc.', 'AbbVie Inc.', 'Pfizer Inc.', 'Novartis International AG', 'Procter & Gamble Co.', 'Roche Holding AG', 'Sanofi SA', 'Serenity Pharmaceuticals LLC', 'Mithra Pharmaceuticals SA', 'In Feb 2022, Nestlé Health Science has completed the final acquisition of Vital Proteins, the one of the leading company in collagen in the United States and a lifestyle and wellness platform offering supplements, beverages and food products. Nestlé Health Science acquired a majority stake in Vital Proteins in 2020.', 'In 2022, TherapeuticsMD, Inc. (NYSE MKT: TXMD), an women’s healthcare company, announced positive top-line results from its pivotal phase 3 Replenish Trial of TX-001HR, an investigational bio-identical hormone therapy combination of 17ß-estradiol and progesterone in a single, oral softgel, for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause in post-menopausal women with an intact uterus', 'In 2021, the US Food and Drug Administration (FDA) approved the first non-hormonal therapy for hot flashes associated with menopause. The therapy, called Brexanolone, is administered intravenously and has been shown to significantly reduce the frequency and severity of hot flashes.', 'In 2021, Elektra Health recently raised $3.75 million to expand its virtual care platform for menopause, which includes personalized treatment plans, online consultations with menopause specialists, and access to digital health tools.'.

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

Report ID: SQMIG35I2115 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 62 | Figures: 78

Global Menopause Market Competitive Landscape

Menopause Market Top Player’s Company Profiles

Pfizer Inc.
Novo Nordisk A/S
Allergan plc
TherapeuticsMD Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Bayer AG
Merck & Co. Inc.
Johnson & Johnson
GlaxoSmithKline plc
Eli Lilly and Company
Amgen Inc.
AbbVie Inc.
Pfizer Inc.
Novartis International AG
Procter & Gamble Co.
Roche Holding AG
Sanofi SA
Serenity Pharmaceuticals LLC
Mithra Pharmaceuticals SA

Menopause Market Recent Developments

In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments.
In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market.

Global Menopause Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.33% during the forecast period (2024-2031).

With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Pfizer Inc.', 'Novo Nordisk A/S', 'Allergan plc', 'TherapeuticsMD Inc.', 'Mylan N.V.', 'Teva Pharmaceutical Industries Ltd.', 'Bayer AG', 'Merck & Co. Inc.', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Eli Lilly and Company', 'Amgen Inc.', 'AbbVie Inc.', 'Pfizer Inc.', 'Novartis International AG', 'Procter & Gamble Co.', 'Roche Holding AG', 'Sanofi SA', 'Serenity Pharmaceuticals LLC', 'Mithra Pharmaceuticals SA', 'In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. ', 'In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. ', 'In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. '

There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.

Owing to concerns about the potential hazards of hormone-based treatments, many women are searching for non-hormonal therapy to treat the symptoms of menopause. As a result, there is an increasing need for non-hormonal treatments such herbal medicines, CBT, and mindfulness-based treatments.

The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

Global Menopause Market Competitive Landscape

Global Menopause Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Menopause Market?

Who are the key vendors in the Global Menopause Market?

What is the key driver of Global Menopause Market?

What is the key market trend for Global Menopause Market?

Which region accounted for the largest share in Global Menopause Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300